Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses.
Paul BensonJennifer KuretskiCynthia DonovanGavin HarperDeanna MerrillAimee A MetznerKatie MycockHannah WallisAndrew P BroganJimena PatarroyoAlan OglesbyPublished in: Infectious diseases and therapy (2024)
Results demonstrate real-world effectiveness of DTG/3TC, with few discontinuations, in people with HIV-1 in test-and-treat settings or with high baseline viral loads.